Literature DB >> 20029458

CASK mutations are frequent in males and cause X-linked nystagmus and variable XLMR phenotypes.

Anna Hackett1, Patrick S Tarpey, Andrea Licata, James Cox, Annabel Whibley, Jackie Boyle, Carolyn Rogers, John Grigg, Michael Partington, Roger E Stevenson, John Tolmie, John Rw Yates, Gillian Turner, Meredith Wilson, Andrew P Futreal, Mark Corbett, Marie Shaw, Jozef Gecz, F Lucy Raymond, Michael R Stratton, Charles E Schwartz, Fatima E Abidi.   

Abstract

Mutations of the calcium/calmodulin-dependent serine protein kinase (CASK) gene have recently been associated with X-linked mental retardation (XLMR) with microcephaly, optic atrophy and brainstem and cerebellar hypoplasia, as well as with an X-linked syndrome having some FG-like features. Our group has recently identified four male probands from 358 probable XLMR families with missense mutations (p.Y268H, p.P396S, p.D710G and p.W919R) in the CASK gene. Congenital nystagmus, a rare and striking feature, was present in two of these families. We screened a further 45 probands with either nystagmus or microcephaly and mental retardation (MR), and identified two further mutations, a missense mutation (p.Y728C) and a splice mutation (c.2521-2A>T) in two small families with nystagmus and MR. Detailed clinical examinations of all six families, including an ophthalmological review in four families, were undertaken to further characterise the phenotype. We report on the clinical features of 24 individuals, mostly male, from six families with CASK mutations. The phenotype was variable, ranging from non-syndromic mild MR to severe MR associated with microcephaly and dysmorphic facial features. Carrier females were variably affected. Congenital nystagmus was found in members of four of the families. Our findings reinforce the CASK gene as a relatively frequent cause of XLMR in females and males. We further define the phenotypic spectrum and demonstrate that affected males with missense mutations or in-frame deletions in CASK are frequently associated with congenital nystagmus and XLMR, a striking feature not previously reported.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 20029458      PMCID: PMC2987321          DOI: 10.1038/ejhg.2009.220

Source DB:  PubMed          Journal:  Eur J Hum Genet        ISSN: 1018-4813            Impact factor:   4.246


  39 in total

Review 1.  The role of the MAGUK protein CASK in neural development and synaptic function.

Authors:  Yi-Ping Hsueh
Journal:  Curr Med Chem       Date:  2006       Impact factor: 4.530

2.  18q deletions: clinical, molecular, and brain MRI findings of 14 individuals.

Authors:  Tarja Linnankivi; Pentti Tienari; Mirja Somer; Marketta Kähkönen; Tuula Lönnqvist; Leena Valanne; Helena Pihko
Journal:  Am J Med Genet A       Date:  2006-02-15       Impact factor: 2.802

3.  A tripartite protein complex with the potential to couple synaptic vesicle exocytosis to cell adhesion in brain.

Authors:  S Butz; M Okamoto; T C Südhof
Journal:  Cell       Date:  1998-09-18       Impact factor: 41.582

4.  The location of human CASK at Xp11.4 identifies this gene as a candidate for X-linked optic atrophy.

Authors:  S D Dimitratos; D G Stathakis; C A Nelson; D F Woods; P J Bryant
Journal:  Genomics       Date:  1998-07-15       Impact factor: 5.736

5.  Mutation screening in Borjeson-Forssman-Lehmann syndrome: identification of a novel de novo PHF6 mutation in a female patient.

Authors:  J Crawford; K M Lower; R C M Hennekam; H Van Esch; A Mégarbané; S A Lynch; G Turner; J Gécz
Journal:  J Med Genet       Date:  2005-07-01       Impact factor: 6.318

6.  Linkage analysis of two families with X-linked recessive congenital motor nystagmus.

Authors:  Xiangming Guo; Shiqiang Li; Xiaoyun Jia; Xueshan Xiao; Panfeng Wang; Qingjiong Zhang
Journal:  J Hum Genet       Date:  2005-10-21       Impact factor: 3.172

7.  X-linked infantile periodic alternating nystagmus.

Authors:  Richard W Hertle; Dongsheng Yang; Kristopher Kelly; Vanessa M Hill; Joan Atkin; Allison Seward
Journal:  Ophthalmic Genet       Date:  2005-06       Impact factor: 1.803

Review 8.  PLP1-related inherited dysmyelinating disorders: Pelizaeus-Merzbacher disease and spastic paraplegia type 2.

Authors:  Ken Inoue
Journal:  Neurogenetics       Date:  2004-12-31       Impact factor: 2.660

9.  Identification of an evolutionarily conserved heterotrimeric protein complex involved in protein targeting.

Authors:  J P Borg; S W Straight; S M Kaech; M de Taddéo-Borg; D E Kroon; D Karnak; R S Turner; S K Kim; B Margolis
Journal:  J Biol Chem       Date:  1998-11-27       Impact factor: 5.157

10.  An olfactory sensory map develops in the absence of normal projection neurons or GABAergic interneurons.

Authors:  A Bulfone; F Wang; R Hevner; S Anderson; T Cutforth; S Chen; J Meneses; R Pedersen; R Axel; J L Rubenstein
Journal:  Neuron       Date:  1998-12       Impact factor: 17.173

View more
  46 in total

1.  Human Neuropsychiatric Disease Modeling using Conditional Deletion Reveals Synaptic Transmission Defects Caused by Heterozygous Mutations in NRXN1.

Authors:  ChangHui Pak; Tamas Danko; Yingsha Zhang; Jason Aoto; Garret Anderson; Stephan Maxeiner; Fei Yi; Marius Wernig; Thomas C Südhof
Journal:  Cell Stem Cell       Date:  2015-08-13       Impact factor: 24.633

Review 2.  Protein sumoylation in brain development, neuronal morphology and spinogenesis.

Authors:  Carole Gwizdek; Frédéric Cassé; Stéphane Martin
Journal:  Neuromolecular Med       Date:  2013-08-02       Impact factor: 3.843

Review 3.  Autism spectrum disorder and epilepsy: Disorders with a shared biology.

Authors:  Bo Hoon Lee; Tristram Smith; Alex R Paciorkowski
Journal:  Epilepsy Behav       Date:  2015-04-19       Impact factor: 2.937

4.  Neuroradiologic features of CASK mutations.

Authors:  J Takanashi; H Arai; S Nabatame; S Hirai; S Hayashi; J Inazawa; N Okamoto; A J Barkovich
Journal:  AJNR Am J Neuroradiol       Date:  2010-07-01       Impact factor: 3.825

Review 5.  Synapse assembly and neurodevelopmental disorders.

Authors:  Philip Washbourne
Journal:  Neuropsychopharmacology       Date:  2014-07-03       Impact factor: 7.853

Review 6.  Intellectual disability and autism spectrum disorders: causal genes and molecular mechanisms.

Authors:  Anand K Srivastava; Charles E Schwartz
Journal:  Neurosci Biobehav Rev       Date:  2014-04-04       Impact factor: 8.989

7.  Two microcephaly-associated novel missense mutations in CASK specifically disrupt the CASK-neurexin interaction.

Authors:  Leslie E W LaConte; Vrushali Chavan; Abdallah F Elias; Cynthia Hudson; Corbin Schwanke; Katie Styren; Jonathan Shoof; Fernando Kok; Sarika Srivastava; Konark Mukherjee
Journal:  Hum Genet       Date:  2018-02-09       Impact factor: 4.132

8.  A novel CASK mutation identified in siblings exhibiting developmental disorders with/without microcephaly.

Authors:  Toshiyuki Seto; Takashi Hamazaki; Satsuki Nishigaki; Satoshi Kudo; Haruo Shintaku; Yumiko Ondo; Keiko Shimojima; Toshiyuki Yamamoto
Journal:  Intractable Rare Dis Res       Date:  2017-08

9.  The molecular basis of the Caskin1 and Mint1 interaction with CASK.

Authors:  Ryan L Stafford; Jason Ear; Mary Jane Knight; James U Bowie
Journal:  J Mol Biol       Date:  2011-07-12       Impact factor: 5.469

10.  Tandem SAM domain structure of human Caskin1: a presynaptic, self-assembling scaffold for CASK.

Authors:  Ryan L Stafford; Elizabeth Hinde; Mary Jane Knight; Mario A Pennella; Jason Ear; Michelle A Digman; Enrico Gratton; James U Bowie
Journal:  Structure       Date:  2011-12-07       Impact factor: 5.006

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.